Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Pelkonen

Showing results (221-230 of 275) with videos related to

Pageof 28
Sort By:
Pharmacology & Toxicology|August 1, 1995
Transfer of lidocaine and bupivacaine across the isolated perfused human placentaT I Ala-Kokko, P Pienimäki, R Herva, et al.
Developmental Pharmacology and Therapeutics|January 1, 1987
Characterization of human fetal hepatic cytochrome P-450-associated 7-ethoxyresorufin O-deethylase and aryl hydrocarbon hydroxylase activities by monoclonal antibodiesM Pasanen, O Pelkonen, A Kauppila, et al.
Human & Experimental Toxicology|January 1, 1996
Immunohistochemical properties of dipyrone-induced cytochromes P450 in ratsH Kraul, M Pasanen, H Sigusch, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 12, 2010
Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktailD K Sevior, J Hokkanen, A Tolonen, et al.
Biochemical Pharmacology|July 5, 1994
Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liverJ Hakkola, M Pasanen, R Purkunen, et al.
British Journal of Clinical Pharmacology|February 1, 1995
Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamineB B Rasmussen, J Maënpää, O Pelkonen, et al.
American Journal of Respiratory Cell and Molecular Biology|March 1, 2000
Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell lineJ Hukkanen, A Lassila, K Päivärinta, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymesM Hidestrand, M Oscarson, J S Salonen, et al.
European Journal of Pharmacology|August 2, 1993
Retrovirus-mediated stable expression of human CYP2A6 in mammalian cellsP Salonpää, J Hakkola, M Pasanen, et al.
Pharmacology & Toxicology|December 1, 1993
Involvement of P450 1A1 in benzo(a)pyrene but not in benzo(a)pyrene-7,8-dihydrodiol activation by 3-methylcholanthrene-induced mouse liver microsomesN Bjelogrlic, R Peng, S S Park, et al.
Pageof 28

Showing results (221-230 of 275) with videos related to

Sort By:
Pageof 28
Pharmacology & Toxicology|August 1, 1995
Transfer of lidocaine and bupivacaine across the isolated perfused human placentaT I Ala-Kokko, P Pienimäki, R Herva, et al.
Developmental Pharmacology and Therapeutics|January 1, 1987
Characterization of human fetal hepatic cytochrome P-450-associated 7-ethoxyresorufin O-deethylase and aryl hydrocarbon hydroxylase activities by monoclonal antibodiesM Pasanen, O Pelkonen, A Kauppila, et al.
Human & Experimental Toxicology|January 1, 1996
Immunohistochemical properties of dipyrone-induced cytochromes P450 in ratsH Kraul, M Pasanen, H Sigusch, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 12, 2010
Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktailD K Sevior, J Hokkanen, A Tolonen, et al.
Biochemical Pharmacology|July 5, 1994
Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liverJ Hakkola, M Pasanen, R Purkunen, et al.
British Journal of Clinical Pharmacology|February 1, 1995
Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamineB B Rasmussen, J Maënpää, O Pelkonen, et al.
American Journal of Respiratory Cell and Molecular Biology|March 1, 2000
Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell lineJ Hukkanen, A Lassila, K Päivärinta, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymesM Hidestrand, M Oscarson, J S Salonen, et al.
European Journal of Pharmacology|August 2, 1993
Retrovirus-mediated stable expression of human CYP2A6 in mammalian cellsP Salonpää, J Hakkola, M Pasanen, et al.
Pharmacology & Toxicology|December 1, 1993
Involvement of P450 1A1 in benzo(a)pyrene but not in benzo(a)pyrene-7,8-dihydrodiol activation by 3-methylcholanthrene-induced mouse liver microsomesN Bjelogrlic, R Peng, S S Park, et al.
Pageof 28